FDA Inspection 997036 — Merck & Co. Inc

Merck & Co. Inc — FEI 2211017

The FDA completed an inspection of Merck & Co. Inc on December 6, 2016 in Rahway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 6, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rahway, NJ (United States)

Additional Details

Sponsor, Contract Research Organization